cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.7201
-0.0298 (-3.97%)
At close: Sep 4, 2025, 4:00 PM
0.7020
-0.0181 (-2.51%)
Pre-market: Sep 5, 2025, 8:15 AM EDT
cbdMD Market Cap
cbdMD has a market cap or net worth of $6.42 million as of September 5, 2025. Its market cap has increased by 251.63% in one year.
Market Cap
6.42M
Enterprise Value
6.32M
1-Year Change
251.63%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since December 21, 2018, cbdMD's market cap has decreased from $28.33M to $6.42M, a decrease of -77.35%. That is a compound annual growth rate of -19.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 6.42M | 208.99% |
| Dec 31, 2024 | 2.08M | -32.55% |
| Dec 29, 2023 | 3.08M | -77.64% |
| Dec 30, 2022 | 13.77M | -78.11% |
| Dec 31, 2021 | 62.93M | -59.08% |
| Dec 31, 2020 | 153.79M | 145.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |